Neuroscientists at Sheba Medical Center have discovered a drug that could potentially cure terminally ill patients suffering from Glioblastoma (GBM), a particularly aggressive form of brain cancer.
Always at the forefront of innovation, Sheba Medical Center is collaborating with international medical institutions to provide patients with the most advanced technologies. Just as the banking, e-commerce, and media industries have put their main thrust into digital tech and mega databases, Sheba is now revolutionizing how digital health can influence patient care around the world.
NBA all-star legend Dikembe Mutombo recently travelled to Israel to meet with international medical experts at Sheba Medical Center. The goal of Mutombo’s visit was to discuss a possible 2019 collaboration between Sheba and the Biamba Marie Mutombo Hospital in the Democratic Republic of Congo.
The 2018 Israel American Council (IAC) National Conference was held recently at the Diplomat Beach Resort in Hollywood, Florida. On December 1, Dr. Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center was honored as a guest speaker in an engaging panel discussion on “The Future of Medicine.”
The Humanitarian Response Team from the Israel Center for Disaster Medicine at Sheba Medical Center was the first international team of doctors, nurses, and lab technicians to respond to the urgent call for help following an outbreak of cholera in Lusaka, Zambia. Cholera is unheard of in Israel, just like in all Western nations. However, Sheba held fast to their commitment to share medical excellence under all circumstances.
A team comprised of several Israeli ophthalmologists and nurses recently set sail for the South Pacific paradise island of Papua New Guinea, where they will perform advanced cataract surgeries. The head of the team is Dr. Eva Platner, an ophthalmologist, and all of the medical specialists represent The Israel Center for Disaster Medicine and Humanitarian Response at Sheba Medical Center.
The Angelman Syndrome Foundation (ASF) recently expanded their international reach into Israel, collaborating with The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Israel to open a new clinic. ASF’s mission is to advance awareness and treatment of AS, and the foundation has funded numerous research grants and clinics. With the addition of the Israeli clinic and another new clinic in The Children’s Hospital of Eastern Ontario in Ottawa, Canada, the ASF now has 10 global locations (eight of which are in the United States).
Dr. Yehuda Shoenfeld, nicknamed the “Godfather of Autoimmunology,” recently published an article in Pharmacological Research with his colleagues that explores how vaccines may be contributing to the growing epidemic of autoimmune diseases. The article is based on massive amounts of research that have been accumulating over the past 15 years.
For the fifth year running, Sheba Medical Center’s Neonatal Intensive Care Unit was awarded the “Excellence in Neonatal Intensive Care” title by the Ministry of Health.
A prostate biopsy is recommended in case of suspected prostate cancer due to increased PSA levels or an abnormal rectal examination, or both.
A fusion biopsy is a smart biopsy guided by MRI scanning. During the test, suspicious areas are noted by the radiologist, and the MRI data is combined with ultrasound images. This combination (fusion) makes it possible to target the biopsy more accurately to suspicious areas, rather than blind piercing, and to increase the rate of disease detection.
The biopsy is managed by a urologist, who takes a small tissue sample from the prostate using a small needle. Then, a tissue sample is sent to the pathological laboratory for microscopic examination.
Established in 1948, Sheba Medical Center is now the leading medical center in the region.
